Distribution of LDL particle size in a population-based sample of children and adolescents and relationship with other cardiovascular risk factors

Clinical Chemistry

Volumn 51, Issue 7, 2005, Pages 1192-1200

  Stan, Simona ^a   Levy, Emile ^a   Delvin, Edgard E ^a   Hanley, James A ^b   Lamarche, Benoît ^c   O'Loughlin, Jennifer ^b   Paradis, Gilles ^b   Lambert, Marie ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; BODY MASS; CANADA; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE MARKER; FEMALE; GEL ELECTROPHORESIS; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PARTICLE SIZE; PHENOTYPE; POPULATION DISTRIBUTION; REVIEW; RISK FACTOR; SCHOOL; SCHOOL CHILD; AGE; ARTICLE; BLOOD; CHEMISTRY; CHILD; DRINKING BEHAVIOR; INSULIN RESISTANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; REGRESSION ANALYSIS; SMOKING;

ADOLESCENT; AGE FACTORS; ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; CHILD; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS, LDL; MALE; PARTICLE SIZE; REGRESSION ANALYSIS; RISK FACTORS; SMOKING;

EID: 23444458253     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.046771     Document Type: Review

References (61)

1. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity [Review]. J Lipid Res 2002;43:1363-79.
2. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ. Effect of gender, age, and lipid status on low-density lipoprotein subfraction distribution. Arteriosclerosis 1987;7:483-90.
3. Campos H, Sacks FM, Walsh BW, Schiff I, O'Hanesian MA, Krauss RM. Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism 1993;42:1153-8.
4. Mauger JF, Lichtenstein AH, Ausman LM, Jalbert SM, Jauhiainen M, Ehnholm C, et al. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr 2003;78:370-5.
5. Sjogren P, Rosell M, Skoglund-Andersson C, Zdravkovic S, Vessby B, de Faire U, et al. Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. J Nutr 2004;134:1729-35.
6. Terry RB, Wood PD, Haskell WL, Stefanick ML, Krauss RM. Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men. J Clin Endocrinol Metab 1989;68:191-9.
7. Tchernof A, Lamarche B, Prud'Homme D, Nadeau A, Moorjani S, Labrie F, et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 1996;19:629-37.
8. Reaven GM, Chen YDI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993;92:141-6.
9. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry C Jr, Mayer EJ, et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993;88:381-7.
10. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 1992;12:1496-502.
11. Austin M, Krauss RM. Genetic control of low-density-lipoprotein subclasses. Lancet 1986;2:592-5.
12. Bosse Y, Perusse L, Vohl MC. Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations [Review]. J Lipid Res 2004;45:1008-26.
13. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoprotein in normal humans. J Lipid Res 1982;23:97-104.
14. Williams PT, Krauss RM, Nichols AV, Vranizan KM, Wood PDS. Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. J Lipid Res 1990;31: 1131-9.
15. Krauss RM, Blanche PJ. Detection and quantitation of LDL subfractions. Curr Opin Lipidol 1992;3:377-83.
16. Wagner AM, Jorba O, Rigla M, Alonso E, Ordonez-Llanos J, Pérez A. LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Acta Diabetol 2002;39:215-20.
17. Tallis GA, Shephard MD, Sobecki S, Whiting MJ. The total apolipoprotein B/LDL-cholesterol ratio does not predict LDL particle size. Clin Chim Acta 1995;240:63-73.
18. Kang H-S, Gutin B, Barbeau P, Litaker MS, Allison J, Le N-A. Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths. Int J Obes Relat Metab Disord 2002;26:1030-5.
19. Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 2000;23:1679-85.
20. HDL). Clin Biochem 2001;34:583-8.
21. Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb 2003;10:186-91.
22. Hanak V, Munoz J, Teague J, Stanley A Jr, Bittner V. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am J Cardiol 2004;94:219-22.
23. Kwiterovich PO Jr. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity [Review]. Am J Cardiol 2002;90:30i-47i.
24. Sacks FM, Campos H. Low-density lipoprotein size and cardiovascular disease: a reappraisal [Review]. J Clin Endocrinol Metab 2003;88:4525-32.
25. Howard BV, Mayer-Davis EJ, Goff D, Zaccaro DJ, Laws A, Robbins DC, et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic Whites: the Insulin Resistance Atherosclerosis Study. Metabolism 1998;47:1174-9.
26. Friedlander Y, Kidron M, Caslake M, Lamb T, McConnell M, Bar-On H. Low density lipoprotein particle size and risk factors of insulin resistance syndrome. Atherosclerosis 2000;148:141-9.
27. Hulthe J, Bokemark L, Wikstrand J, Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) Study. Arterioscler Thromb Vasc Biol 2000;20:2140-7.
28. Bjornheden T, Babyi A, Bondjers G, Wiklund O. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis 1996;123: 43-56.
29. Campos H, Arnold KS, Balestra ME, Innerarity TL, Krauss RM. Differences in receptor binding of LDL subfractions. Arterioscler Thromb Vasc Biol 1996;16:794-801.
30. Galeano NF, Al-Haideri M, Keyserman F, Rumsey SC, Deckelbaum RJ. Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. Lipid Res 1998;39: 1263-73.
31. Anber V, Millar JS, McConnell M, Shepherd J, Packard CJ. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans. Arterioscler Thromb Vasc Biol 1997;17:2507-14.
32. Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993;94:350-6.
33. Tribble DL, Rizzo M, Chait A, Lewis DM, Blanche PJ, Krauss RM. Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. Am J Med 2001;110:103-10.
34. Arisaka O, Kojima M, Yamazaki Y, Kanazawa S, Koyama S, Shimura N, et al. Relationship between the presence of small, dense low-density lipoprotein and plasma lipid phenotypes in Japanese children. J Atheroscler Thromb 2004;11:220-3.
35. Kaitosaari T, Ronnemaa T, Raitakari O, Talvia S, Kallio K, Volanen I, et al. Effect of 7-year infancy-onset dietary intervention on serum lipoproteins and lipoprotein subclasses in healthy children in the prospective, randomized Special Turku Coronary Risk Factor Intervention Project for Children (STRIP) study. Circulation 2003;108: 672-7.
36. Shea S, Aymong E, Zybert P, Berglund L, Shamoon H, Deckelbaum RJ, Basch CE. Fasting plasma insulin modulates lipid levels and particle sizes in 2-to 3-year-old children. Obes Res 2003;11:709-21.
37. Ohta T, Kakiuti Y, Kurahara K, Saku K, Nagata N, Matsuda I. Fractional esterification rate of cholesterol in high density lipoprotein is correlated with low density lipoprotein particle size in children. J Lipid Res 1997;38:139-46.
38. Shimabukuro T, Sunagawa M, Ohta T. Low-density lipoprotein particle size and its regulatory factors in school children. J Clin Endocrinol Metab 2004;89:2923-7.
39. Freedman DS, Bowman BA, Otvos JD, Srinivasan SR, Berenson GS. Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa Heart Study. Atherosclerosis 2000;152: 441-9.
40. Williams PT, Krauss RM. Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses. Arterioscler Thromb Vasc Biol 1997;17:1082-90.
41. Arisaka O, Fujiwara S, Yabuta K, Mokuno H, Mitugi Y, Miyake N. Characterization of low-density lipoprotein subclasses in children. Metabolism 1997;46:146-8.
42. Steinbeck KS, Bermingham MA, Mahajan D, Baur LA. Low-density lipoprotein subclasses in children under 10 years of age. J Paediatr Child Health 2001;37:550-3.
43. Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002;106:143-60.
44. McGill HC Jr, McMahan CA, Herderick EE, Malcom GT, Tracy RE, Strong JP. Origin of atherosclerosis in childhood and adolescence [Review]. Am J Clin Nutr 2000;72:1307S-15S.
45. Lambert M, Paradis G, O'Loughlin J, Delvin EE, Hanley JA, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada, Int J Obes Relat Metab Disord 2004;28:833-41.
46. Paradis G, Lambert M, O'Loughlin J, Lavallee C, Aubin J, Berthiaume P, et al. The Quebec Child and Adolescent Health and Social Survey: design and methods of a cardiovascular risk factor survey for youth. Can J Cardiol 2003;19:523-31.
47. US Department of Health and Human Services. CDC growth charts: United States. DHHS publication no. 2000-1250. December 2000:28 pp. http://www.cdc.gov/nchs/data/ad/ad314.pdf (accessed April 14, 2005).
48. Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996; 98:649-58.
49. Allard P, Delvin EE, Paradis G, Hanley JA, O'Loughlin J, Lavallee C, et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clin Chem 2003;49:644-9.
50. Friedewald WF, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1977;18:499-502.
51. Hutson AD. Calculating nonparametric confidence intervals for quantiles using fractional order statistics. J Appl Stat 1999;26: 343-53.
52. Witte DR, Taskinen MR, Perttunen-Nio H, Van Tol A, Livingstone S, Colhoun HM. Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis. J Lipid Res 2004;45:1069-76.
53. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, et al. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem 2004;50:1189-200.
54. Campos H, Blijlevens E, McNamara JR, Ordovas JM, Posner BM, Wilson PW, et al. LDL particle size distribution. Results from the Framingham Offspring Study. Arterioscler Thromb 1992;12: 1410-9.
55. Lahdenpera S, Sane T, Vuorinen-Markkola H, Knudsen P, Taskinen MR. LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes. Atherosclerosis 1995;113:227-36.
56. Slyper AH, Zvereva S, Schectman G, Hoffmann RG, Mueller RA, Walker JA. Insulin resistance is not a major determinant of low-density lipoprotein particle size. Metabolism 1997;46:1275-80.
57. Mykkanen L, Haffner SM, Rainwater DL, Karhapaa P, Miettinen H, Laakso M. Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler Thromb Vasc Biol 1997;17: 1447-53.
58. Ambrosch A, Muhlen I, Kopf D, Augustin W, Dierkes J, Konig W, et al. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects. Diabetes Care 1998;21:2077-84.
59. Fagerberg B, Hulthe J, Bokemark L, Wikstrand J. Low-density lipoprotein particle size, insulin resistance, and proinsulin in a population sample of 58-year-old men. Metabolism 2001;50: 120-4.
60. Malmstrom R, Packard CJ, Watson TD, Rannikko S, Caslake M, Bedford D, et al. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 1997;17: 1454-64.
61. Bioletto S, Golay A, Munger R, Kalix B, James RW. Acute hyperinsulinemia and very-low-density and low-density lipoprotein subtractions in obese subjects. Am J Clin Nutr 2000;71:443-9.